Spontaneous rat model of alopecia areata in the dundee experimental bald rat (DEBR)

Animal Models of Human Inflammatory Skin Diseases

Volumn , Issue , 2003, Pages 451-468

  McElwee, Kevin J ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 73649136243     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (67)

1. Dawber, D., de Berker, D., and Wojnarowska, F., Disorders of hair: alopecia areata, in Rook/Wilkinson/Ebling Textbook of Dermatology, Champion, R.H., et al., Eds., Blackwell Science, Oxford, 1998, p. 2919.
2. Safavi, K.H., et al., Incidence of alopecia areata in Olmsted County, Minnesota 1975 through 1989, Mayo Clin. Proc., 70, 628, 1995.
3. Thompson, W. and Shapiro, J., Alopecia Areata: Understanding and Coping with Hair Loss, Johns Hopkins University Press, Baltimore, 1996, p. 2.
4. Goldsmith, L.A., Summary of alopecia areata research workshop and future research directions, J. Invest. Dermatol., 96, 98, 1991.
5. McElwee, K.J., Third International Research Workshop on Alopecia Areata, J. Invest. Dermatol., 112, 822, 1999.
6. Olsen, E., et al., Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation, J. Am. Acad. Dermatol., 40, 242, 1999.
7. McDonagh, A.J. and Messenger, A.G., The pathogenesis of alopecia areata, Dermatol. Clin., 14, 661, 1996.
8. Perret, C., Wiesner-Menzel, L., and Happle, R., Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata, Acta Derm. Venereol., 64, 26, 1984.
9. Ranki, A., et al., Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis), J. Invest. Dermatol., 83, 7, 1984.
10. Gupta, A.K., et al., Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistological analysis, J. Am. Acad. Dermatol., 22, 242, 1990.
11. Tobin, D.J., et al., Antibodies to hair follicles in alopecia areata, J. Invest. Dermatol., 102, 721, 1994.
12. McElwee, K.J., et al., Alopecia areata: an autoimmune disease? Exp. Dermatol., 8, 371, 1999.
13. Conroy, J.D., Alopecia areata, in Spontaneous Animal Models of Human Disease, Andrew, E.J., Ward, B.C., and Altman, N.H., Eds., Academic Press, New York, 1979, p. 30.
14. McElwee, K.J., et al., Comparison of alopecia areata in human and nonhuman mammalian species, Pathobiology, 66, 90, 1998.
15. Smyth, J.R. Jr. and McNeil, M., Alopecia areata and universalis in the Smyth chicken model for spontaneous autoimmune vitiligo, J. Investig. Dermatol. Symp. Proc., 4, 211, 1999.
16. Sundberg, J.P. and King, L.E. Jr., Mouse mutations as animal models and biomedical tools for dermatological research, J. Invest. Dermatol., 106, 368, 1996.
17. McElwee, K.J., et al., Spontaneous alopecia areata-like hair loss in one congenic and seven inbred laboratory mouse strains, J. Investig. Dermatol. Symp. Proc., 4, 202, 1999.
18. Sundberg, J.P., Cordy, W.R., and King, L.E. Jr., Alopecia areata in aging C3H/HeJ mice, J. Invest. Dermatol., 102, 847, 1994.
19. Michie, H.J., et al., The DEBR rat: an animal model of human alopecia areata, Br. J. Dermatol., 125, 94, 1991.
20. Oliver, R.F., et al., The DEBR rat model for alopecia areata, J. Invest. Dermatol., 96, 97, 1991.
21. Druckery, H., Genotypes and phenotypes of ten inbred strains of BD-rats, Arnzneim-Forsch., 21, 1274, 1971.
22. Levan, K.K., et al., Rat gene map, Rat Genome, 2, 30, 1996.
23. McElwee, K.J., et al., Genetic susceptibility and severity of alopecia areata in human and animal models, Eur. J. Dermatol., 11, 11, 2001.
24. Kendall, C., et al., Characterization of strain specific typing antisera for genetic monitoring of inbred strain of rats, Lab. Anim. Sci., 35, 364, 1985.
25. Male, D.K., Pryce G., and Butcher G.W., Serological evidence for a defect in RT1.B (I-A) expression by the BDIX rat strain, J. Immunogenet., 14, 301, 1987.
26. Peerboom-Wynia, J.G.R., et al., Scanning E.M.comparing exclamation mark hairs in alopecia areata with normal hair fibres mechanically broken by traction, Clin. Exp. Dermatol., 14, 47, 1989.
27. Michie, H.J., et al., Immunobiological studies on the alopecic (DEBR) rat, Br. J. Dermatol., 123, 557, 1990.
28. Zhang, J.G. and Oliver, R.F., Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata, Br. J. Dermatol., 130, 405, 1994.
29. McElwee, K.J., Pickett, P., and Oliver, R.F., Hair follicle autoantibodies in DEBR rat sera, J. Invest. Dermatol., 104, 34, 1995.
30. McElwee, K.J., Pickett, P., and Oliver, R.F., Autoantibodies to the hair follicle in sera from the DEBR rat model for alopecia areata, Br. J. Dermatol., 134, 55, 1996.
31. McElwee, K.J., Drummond, S., and Oliver, R.F., Hair follicle specific autoantibodies associated with alopecia areata in sera from the DEBR rat model and humans, Excerpta Medica Int. Congress, 1111, 253, 1996.
32. Freyschmidt-Paul, P., et al., Current and potential agents for the treatment of alopecia areata, Curr. Pharmacol. Design, 7, 213, 2001.
33. Sundberg, J.P., et al., Alopecia areata in humans and other mammalian species, J. Invest. Dermatol., 104, 33s, 1995.
34. Pascher, F., Kurtin, S., and Andrade, R., Assay of 0.2% fluocinolone acetonide cream for alopecia areata and totalis, Dermatologica, 141, 193, 1970.
35. Leyden, J.J. and Kligman, A.M., Treatment of alopecia areata with steroid solution, Arch. Derm., 106, 924, 1972.
36. Lehnert, W., Zur Lokalbehandlung schwerer Formen der Alopecia Areata mit Kortikosteroidsalbe, Derm. Mschr., 160, 396, 1974.
37. Kalkoff, K.W. and Macher E., Über das Nachwachsen der Haare bei der Alopecia areata und maligna nach intracutaner Hydrocortisoninjektion, Hautarzt, 9, 441, 1958.
38. Orentreich, N., et al., Local injection of steroids and hair regrowth in alopecias, Arch. Dermatol., 82, 894, 1960.
39. Abell, E. and Munro D.D., Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector, Br. J. Dermatol., 88, 55, 1973.
40. Dillaha, C.J. and Rothman, S., Therapeutic experiments in alopecia areata with orally administered cortisone, JAMA, 150, 546, 1952.
41. Burton, J.L. and Shuster, S., Large doses of glucocorticoid in the treatment of alopecia areata, Acta Dermatoven., 55, 493, 1975.
42. Perriard-Wolfensberger, J., et al., Pulse of methylprednisolone in alopecia areata, Dermatology, 187, 282, 1993.
43. Sharma, V.K., Pulsed administration of corticosteroids in the treatment of alopecia areata, Int. J. Dermatol., 35, 133, 1996.
44. Friedli, A., et al., Pulse methyprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients, J. Am. Acad. Deramtol., 39, 597, 1998.
45. Shapiro, J., et al., Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation, J. Am. Acad. Dermatol., 29, 729, 1993.
46. Swanson, N.A., et al., Topical treatment of alopecia areata, Arch. Dermatol., 117, 384, 1981.
47. Flowers, F.P., et al., Topical squaric acid dibutylester therapy for alopecia areata, Cutis, 30, 733, 1982.
48. Hoffmann, R., et al., Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone, J. Invest. Dermatol., 103, 530, 1994.
49. Paquet, P., et al., Oral cyclosporin and alopecia areata, Dermatology, 185, 314, 1992.
50. Ferrando, J. and Grimalt, R., Partial response of severe alopecia areata to cyclosporine A, Dermatology, 199, 67, 1999.
51. Parodi, A., et al., Alopecia universalis and cyclosporin A, Br. J. Dermatol., 135, 657, 1996.
52. Mauduit, G., et al., Treatment of severe alopecia areata with topical applications of cyclosporin A, Ann. Dermatol. Venereol., 114, 507, 1987.
53. Parodi, A. and Rebora, A., Topical cyclosporine in alopecia areata, Arch. Dermatol., 123, 165, 1987.
54. de Prost, Y., et al., Placebo-controlled trial of topical cyclosporin in severe alopecia areata, Lancet, 2, 803, 1986.
55. Gilhar, A., Pillar, T., and Etzioni, A., Topical cyclosporin A in alopecia areata, Acta. Derm. Venereol., 69, 252, 1989.
56. Sainsbury, T.S.L., et al., Differential effects of FK506 and cyclosporine on hair regrowth in the DEBR model of alopecia areata, Transplant. Proc., 23, 3332, 1991.
57. Oliver, R.F. and Lowe, J.G., Oral cyclosporin A restores hair growth in the DEBR rat model for alopecia areata, Clin. Exp. Dermatol., 20, 127, 1995.
58. McElwee, K.J., Lowe, J.G., and Oliver, R.F., Effects of potent immunotherapies, oral cyclosporin A and topical FK506, in the DEBR rat model for alopecia areata, Excerpta Medica Int. Congress, 1111, 259, 1996.
59. Verma, D.D., et al., Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesicles, J. Exp. Dermatol., in press.
60. Schreiber, S.L. and Crabtree, G.R., The mechanism of action of cyclosporin A and FK506, Immunol. Today, 13, 136, 1992.
61. McElwee, K.J., et al., Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model, Br. J. Dermatol. 137, 491, 1997.
62. Nakagawa, H., et al., Tacrolimus ointment for atopic dermatitis, Lancet, 344, 883, 1994.
63. Ruzicka, T., et al., A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group, N. Engl. J. Med., 337, 8161, 1997.
64. Alaiti, S., et al., Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children, J. Am. Acad. Dermatol., 38, 69, 1998.
65. + T cells restores hair growth in the DEBR model of alopecia areata, Br. J. Dermatol., 135, 211, 1996.
66. + T cells, Br. J. Dermatol., 140, 432, 1999.
67. Marrack, P., Kappler, J., and Kotzin, B.L., Autoimmune disease: why and where it occurs, Nat. Med., 7, 899, 2001.